Home › NDC Lookup › RxCUI directory › RxCUI 2283049

1 ML eptinezumab-jjmr 100 MG/ML Injection — RxCUI 2283049

Name: 1 ML eptinezumab-jjmr 100 MG/ML Injection (RxCUI 2283049)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2283049 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2283049

Official name1 ML eptinezumab-jjmr 100 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known aseptinezumab-jjmr 100 MG per 1 ML Injection; eptinezumab-jjmr 100 MG in 1 mL Injection

FDA products mapped1

Package NDCs mapped2

Reported Medicaid activity (SDUD)8,909 prescriptions · 46 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Eptinezumab-jjmr Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Vyepti is a preventive treatment, not a rescue medicine. That means it won't stop a migraine that's already started. Instead, it works in the background to reduce how often migrain...
What exactly does Vyepti do — is it supposed to stop a migraine or prevent one?
Vyepti is given as an IV infusion once every 3 months — so just four visits a year. Each infusion takes about 30 minutes and is done in a clinical setting like your doctor's office...
How often do I need to come in for the infusion?

📖 Read our full Eptinezumab-jjmr Injection guide →

🕸️ Concept Web — How 1 ML eptinezumab-jjmr 100 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 1 ML eptinezumab-jjmr 100 MG/ML Injection RxCUI 2283049 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Eptinezumab 2282660 IN
- Eptinezumab-jjmr 2283045 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Vyepti 2283050 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Eptinezumab Injection 2283048 SCDF
- Eptinezumab-jjmr Injection 2645347 SCDFP
- Eptinezumab Injectable Product 2283047 SCDG
- Eptinezumab-jjmr Injectable Product 2659418 SCDGP
- Eptinezumab Injection [Vyepti] 2283052 SBDF
- Eptinezumab-jjmr Injection [Vyepti] 2655942 SBDFP
- Vyepti Injectable Product 2283053 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Eptinezumab-jjmr 100 MG/ML 2283046 SCDC
- 1 ML eptinezumab-jjmr 100 MG/ML Injection [Vyepti] 2283054 SBD
- Eptinezumab-jjmr 100 MG/ML [Vyepti] 2283051 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Eptinezumab-jjmr 100 MG/ML SCDC · 2283046
Eptinezumab Injection SCDF · 2283048
Eptinezumab-jjmr Injection SCDFP · 2645347
Eptinezumab Injectable Product SCDG · 2283047
Eptinezumab-jjmr Injectable Product SCDGP · 2659418

Brand-Name Concepts

1 ML eptinezumab-jjmr 100 MG/ML Injection [Vyepti] SBD · 2283054
Eptinezumab-jjmr 100 MG/ML [Vyepti] SBDC · 2283051
Eptinezumab Injection [Vyepti] SBDF · 2283052
Eptinezumab-jjmr Injection [Vyepti] SBDFP · 2655942
Vyepti Injectable Product SBDG · 2283053
Vyepti BN · 2283050

📦 FDA Products & Package NDCs

1 product · 2 package NDCs

2 package NDCs map to RxCUI 2283049 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
67386-0130-51	1 VIAL, SINGLE-DOSE in 1 CARTON (67386-130-51) / 1 mL in 1...	Vyepti	Lundbeck Pharmaceuticals LLC	2020-02-21
67386-0130-91	1 VIAL, SINGLE-DOSE in 1 CARTON (67386-130-91) / 1 mL in 1...	Vyepti	Lundbeck Pharmaceuticals LLC	2023-04-01

Observed labelers: Lundbeck Pharmaceuticals LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J3032	Inj. eptinezumab-jjmr 1 mg	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.